Atul receives USFDA approval for Dapsone manufacture facility

15 Jan 2015 Evaluate

Atul’s Dapsone manufacture facility located at Valsad in state of Gujarat has been approved by the US Food and Drug Administration (USFDA).

The company has two business segments, namely, ‘Life Science Chemicals’ and ‘Performance and Other Chemicals’. The Life Science Chemical segment comprises several manufacturing facilities which also include Dapsone manufacture facility.

Atul is a member of Lalbhai Group, one of the oldest business houses of India, with interests mainly in textiles and chemicals. The Group is strongly committed to serve the society in the fields of education, health as well as culture.

Atul Share Price

5862.10 110.00 (1.91%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4039.90
Tata Chemicals 773.85
SRF 2886.20
Pidilite Inds. 1474.70
Deepak Nitrite 1565.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×